4.6 Review

Hypothermic neuroprotection against acute ischemic stroke: The 2019 update

期刊

出版社

SAGE PUBLICATIONS INC
DOI: 10.1177/0271678X19894869

关键词

Hypothermia; neuroprotection; brain ischemia; reperfusion; selective cooling

资金

  1. National Key R&D Program of China [2017YFC1308401, 2016YFC1301502]
  2. Chang Jiang Scholars Program from the Chinese Ministry of Education [T2014251]
  3. National Natural Science Foundation of China [81701287, 81871022, 81601006, 81620108011]
  4. Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [ZYLX201706]

向作者/读者索取更多资源

Acute ischemic stroke is a leading cause of death and disability worldwide. Therapeutic hypothermia has long been considered as one of the most robust neuroprotective strategies. Although the neuroprotective effects of hypothermia have only been confirmed in patients with global cerebral ischemia after cardiac arrest and in neonatal hypoxic ischemic encephalopathy, establishing standardized protocols and strictly controlling the key parameters may extend its application in other brain injuries, such as acute ischemic stroke. In this review, we discuss the potential neuroprotective effects of hypothermia, its drawbacks evidenced in previous studies, and its potential clinical application for acute ischemic stroke especially in the era of reperfusion. Based on the different conditions between bench and bedside settings, we demonstrate the importance of vascular recanalization for neuroprotection of hypothermia by analyzing numerous literatures regarding hypothermia in focal cerebral ischemia. Then, we make a thorough analysis of key parameters of hypothermia and introduce novel hypothermic therapies. We advocate in favor of the process of clinical translation of intra-arterial selective cooling infusion in the era of reperfusion and provide insights into the prospects of hypothermia in acute ischemic stroke.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据